Global Preclinical CRO Market
Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Forecast 2023-2030
March 14, 2024 13:31 ET | Research and Markets
Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology,...
22157.jpg
Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares
March 07, 2024 12:09 ET | Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Oncology-based In-Vivo CRO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Industry Anticipates Major...
Global Preclinical Assets Market
Preclinical Assets Market to Surge, Spotlight on Advances in Asia-Pacific
March 07, 2024 12:03 ET | Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Assets Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global preclinical assets market has...
22157.jpg
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond
February 29, 2024 04:06 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Report 2024: Comprehensive Insight on All Drugs in the Clinical Pipeline by Company, Indication & Phase
February 29, 2024 04:05 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
In Silico Clinical Trials Market Report 2023-2033 - Expanded Therapeutic Areas Present Lucrative Opportunities
February 16, 2024 04:09 ET | Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market...
22157.jpg
Global DLL3 Targeted Therapy Market Research Report 2024 - Innovations, Opportunities, Market Trends & Clinical Trials Insights
February 01, 2024 03:16 ET | Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Overview of SAb Biotherapeutics' Drug SAB-176: Phase IIb Trial Insights, SWOT Analysis, and Market Forecast to 2032
January 30, 2024 05:31 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "SAB-176 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a...
Global Patient-Derived Xenograft/PDX Model Market
Global Patient-Derived Xenograft/PDX Model Market Set to Expand with Growing Emphasis on Personalized Medicine and Cancer Research
January 30, 2024 05:20 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mice, Rat), Implantation Method (Subcutaneous, Orthotopic), Tumor Type (Respiratory,...
22157.jpg
Analysis of DNAtrix's Drug DNX-2401, 2023 to 2032: A Promising Candidate for Glioblastoma Multiforme (GBM) Treatment
January 30, 2024 05:01 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "DNX-2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical industry...